from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0649/fabD2

LFCtreatmentdescriptionclass of inhibitor

0.965

Amikacinug/mL Amikacintranslation

1.606

Cap5-10ug/mL Capreomycintranslation

2.608

Rox10-50 ug/mL Roxithromycintranslation

0.970

SM2-5 ug/mL Streptomycintranslation

3.830

Tet5-10 ug/mL Tetracyclinetranslation

0.250

Rif0.2-5ug/mL Rifampicintranscription

-0.215

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.135

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.683

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.441

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.820

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.860

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.799

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.336

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.163

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.390

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.845

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.407

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.461

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.621

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.782

KCN5-20 ug/mL Potassium cyaniderespiration

0.485

NaN30.2-2 mM Sodium aziderespiration

-0.691

Nigericin50 uM Nigericinrespiration

0.427

TRC10-150 ug/mL Triclosanrespiration

0.094

TRZ10-25 ug/mL Thioridazinerespiration

0.410

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.235

menadione6-10 ug/mL Menadionerespiration

0.913

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.116

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.627

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.859

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.771

NRP_1Non-replicating persistence stage 1dosRassociated

-0.857

Amp0.2mg/mL AmpicillincellWall

-0.209

Cephalexin20-100 ug/mL CephalexincellWall

0.043

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.190

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.083

EMB10-20 ug/mL EthambutolcellWall

-0.363

Eta12-40 ug/mL EthionamidecellWall

-0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.032

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.860

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.002

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.835

BZA0.12 mg/mL BenzamidearomaticAmides

-0.632

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.412

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.816

H2O24 mM hydrogen peroxideDNAdamaging

0.126

Levo10 ug/mL LevofloxacinDNAdamaging

-0.003

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.349

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.357

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.055

UVUV-irradiationDNAdamaging

0.555

ARP41-4 ug/mL Antitubercular compound ARP4?

0.027

Antimycin12.5-50 ug/mL Antimycin A?

-0.390

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.179

PA_110-50 ug/mL Antitubercular compound PA-1?

0.301

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.974

PA8240.2-2 ug/mL PA-824?

0.569

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.557

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.320

Verapamil50 uM Verapamil?

-0.258

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.564

methoxatin10-20 ug/mL Methoxatin?